On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) published the final guidance for the third cycle of the Medicare Drug Price Negotiation Program, initial price applicability year (IPAY) 2028. This guidance release occurred on the same day as a more heavily publicized drug pricing announcement, although the morning announcement contained a […]
